Millennium Management
DNA icon

Millennium Management’s Ginkgo Bioworks DNA Stock Holding History

Millennium Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.33M Buy
638,676
+150,719
+31% +$1.26M ﹤0.01% 2769
2026
Q1 		$2.99M Buy
487,957
+439,056
+898% +$3.65M ﹤0.01% 3466
2025
Q4 		$406K Buy
48,901
+26,037
+114% +$280K ﹤0.01% 5075
2025
Q3 		$333K Sell
22,864
-1,331,753
-98% -$15.9M ﹤0.01% 5295
2025
Q2 		$15.2M Sell
1,354,617
-72,983
-5% -$565K 0.01% 1836
2025
Q1 		$8.14M Buy
1,427,600
+757,535
+113% +$7.72M ﹤0.01% 2393
2024
Q4 		$6.58M Buy
670,065
+523,571
+357% +$4.49M ﹤0.01% 2576
2024
Q3 		$1.19M Buy
146,494
+91,996
+169% +$922K ﹤0.01% 4127
2024
Q2 		$729K Sell
54,498
-209,880
-79% -$6.26M ﹤0.01% 4342
2024
Q1 		$12.3M Buy
264,378
+32,718
+14% +$1.69M 0.01% 2000
2023
Q4 		$15.7M Buy
231,660
+71
+0% +$4.35K 0.01% 1758
2023
Q3 		$16.8M Buy
231,589
+49,574
+27% +$3.96M 0.01% 1577
2023
Q2 		$13.5M Buy
+182,015
New +$10.8M 0.01% 1726
2022
Q4 		– Sell
-2,743
Closed -$252K – 6651
2022
Q3 		$342K Sell
2,743
-73,732
-96% -$8.79M ﹤0.01% 5262
2022
Q2 		$7.28M Buy
76,475
+22,154
+41% +$2.7M ﹤0.01% 2397
2022
Q1 		$8.76M Buy
54,321
+38,574
+245% +$7.51M ﹤0.01% 2301
2021
Q4 		$5.23M Sell
15,747
-22,039
-58% -$10.5M ﹤0.01% 2864
2021
Q3 		$17.5M Buy
+37,786
New +$18.4M 0.01% 1449

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Millennium Management's DNA Position: Q2 2026 in Review

Millennium Management increased its Ginkgo Bioworks (DNA) stake by 31% in Q2 2026, buying an estimated $1.26M and bringing the position to 638,676 shares worth $6.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2769.

Millennium Management first reported a position in DNA in Q3 2021 and has held it in 18 quarters since. The position peaked at $17.5M in Q3 2021. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Millennium Management held 638,676 shares of Ginkgo Bioworks worth $6.33M as of Q2 2026.
  • Millennium Management bought 150,719 Ginkgo Bioworks shares in Q2 2026, an estimated $1.26M.
  • Ginkgo Bioworks made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #2769 holding.
  • Millennium Management first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 18 quarters since.
  • Millennium Management's Ginkgo Bioworks position peaked at $17.5M in Q3 2021.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.